Hybridan Small Cap Feast - 07 Mar 23

7 March 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objective

Cenkos: Duke Royalty Ltd -- New Partner in Store for Duke

This morning, Duke announced its newest royalty partner as Instor Solutions, which is a data centre infrastructure installation business based in California. The $8.75m investment will facilitate a management buyout of the majority shareholders of the business. This financing will have terms in-line with Duke's existing investments and diversify the current portfolio to 15 partners. We leave forecasts unchanged as we already forecast a level of capital deployment throughout the year. Duke's valu

Cenkos: Duke Royalty Ltd -- Positive Q4 Update and Guidance

Duke has released a positive Q4/23E trading update in-line with our expectations. With the latest guided quarterly recurring cash revenues of £5.7m, the total for FY23E would be £21.7m, exactly in-line with our forecasts and demonstrating the reliability of forecast cash flows. Further deployments took place during the quarter which will continue to support further revenue growth in FY24E. Duke's valuation looks very compelling at current levels with the FY24E dividend yield at c9% whilst being

FLASH: Refinance and upsize of credit facility

Cenkos: Duke Royalty Ltd -- A New Half and a New Path

Duke has released a resilient set of interim results and a Q3/23E trading update and remains on track to hit our full-year estimates. H1/23A recurring cash revenues were up 67% YoY, and Q3/23E should see a further 4% increase. The Group has a further c£15m of liquidity to deploy following the equity raise earlier this year and the recent investment in a new partner called New Path Fire and Security. We believe deployment will be higher in the second half than the first. The business model contin

In-line H1'23 results; well positioned

Hybridan Small Cap Feast 25/11/22

Dish of the day Joiners: No joiners today. Leavers: Euromoney Institutional Investor has left the Premium Segment of the Main Market. What’s cooking in the IPO kitchen?** Conviction Life Sciences, a newly established closed-ended investment company managed by Plain English Finance Limited, is seeking to list on Premium Segment of the Main Market of the London Stock Exchange, to invest in a conviction portfolio of life sciences and medical technology businesses, primarily in the UK, Europe and Au

Cenkos: Duke Royalty Ltd - Noble Set of Annual Results

Duke have released their annual results for the FY22A year ending 31 March 2022 and are in-line with both their prior trading update and our own expectations. FY22A was a behemoth year for the business as it transitioned from a more defensive positioning during the outset of the pandemic to an expansionary phase as things began to settle. We have released forecasts for FY24E for the first time and is a useful gauge for what a normalised year looks like post-deployment of available funds during F

Material growth in FY22; strong FY23 to date

Cenkos:Duke Royalty Ltd -Record revenues keep on rolling

Cenkos:Duke Royalty Ltd -Record revenues keep on rolling

Cenkos: Duke Royalty Ltd -- Majestic Royalty Expansion

Duke has raised £20m in new equity capital, subject to shareholder approval, to fund their continued expansion. The new capital will also support the company's target of increasing their debt facility by a further £25m, and therefore providing a total of £45m of new capital to invest. The increasing scale and diversification of the portfolio is forecast to eventually increase free cash flow per share once full deployment has taken place and will allow Duke to seek a reduction in its debt facilit

Hybridan Small Cap Feast 28/04/22

Joiners: No joiners today. Leavers: No leavers today. What’s cooking in the IPO kitchen? Altona Rare Earths, the AQSE listed mining exploration company focused on the evaluation, acquisition and development of Rare Earth Elements mining projects in Africa, intends to join the Main Market. Admission to trading of the Company's Ordinary Shares on the AQSE Growth Market will be cancelled simultaneously with Admission. It is also proposed that on Admission, the Company will change its EPIC from AQSE

Cenkos: Duke Royalty Ltd -- Effective Capital Deployment

Today, Duke have announced a positive trading update indicating record quarterly and annual revenues following a number of recent top-up investments in existing partners. As a result, we are upgrading FY22E and FY23E forecasts. The company is now expected to have a free cash flow per share of 3.3p in FY23E, which supports a dividend per share of 3p and a dividend yield of 7.5%. Furthermore, this income is naturally resilient to inflation given distribution resets are tied to top-line revenue gro

Very strong progress in FY22

Uncertain outlook comes as no surprise

We take a positive view of Legal & General’s FY 22 results. Despite the tough environment, the Group managed to outperform expectations – something which was hardly a given for such a large asset manager. With L&G being widely exposed to the UK economy, it might be a call one does not want to make but the firm’s business remains one of spreads – as long as a default does not occur. We remain positive but concede that L&G embeds more risk than we had assumed.

Very strong CY22 - CY23 upgraded 10%

LIBERUM: Alpha Group International* - Highly attractive global growth opportunity

Hybridan Small Cap Feast - 06 Mar 23

6 March 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objective

LIBERUM: Real Estate Investors* - Profitable sales drive valuation increase and NTA outperformance

Equals Group (EQLS LN) - Platform for growth

Revenue rose 59% to £69.7m (consensus: £66.2m; Zeus forecast £65.0m); revenue per day rose 60% to £279k Equals Group’s 2022 results and 1Q trading update reaffirm our view on Equals’ valuation. It has made two bolt-on acquisitions, subject to regulatory approval, which add clear value. Organic growth remains strong: “revenues per working day so far in 2023 were £342k” up 52% yoy and up 13% on 4Q 2022.

Belvoir Group - Debt free, entrepreneurial and diverse

2022 followed on from the strongest year for property in recent history, but Belvoir has, nevertheless, reported a robust set of full-year results further evidencing the power of its franchised model and strategy. FY 2022 revenue was up +14% (+2% like-for-like), gross profit up +6% and adj. PBT down -1% as the resilient Lettings income and expanding Financial Services business continued to grow (both +4% LFL), while housing Sales fell (-15% LFL) as market conditions weakened and administrative c

Morning Note – 27 March 2023

LIBERUM: Aquis Exchange* - Delivering on growth

Encouraging CY22 result

Hybridan Small Cap Feast - 14 Mar 23

14 March 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectiv

LIBERUM: Pollen Street * - Clear fundraising momentum

Cenkos: Personal Group Holdings Plc -- Momentum building

Personal Group's FY22 results show good underlying growth in both API and ARR, with significant HoH EBITDA expansion also delivered in H2. The growth in its insurance book and increased levels of ARR provides high levels of visibility into 2023. Retention rates are high, the group has added 101 new clients and its expansion into the SME market is growing rapidly. Today's results demonstrate the clear benefits of the diversification of the model since 2019 and the ongoing relevance of its offerin

Hybridan Small Cap Feast - 27 Mar 23

27 March 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectiv

NAHL Group - Finals

NAHL generated growth in both its Personal Injury (PI) and Critical Care divisions, the former despite a continuation of subdued market conditions – hence market share gains. Results were in line with our forecasts but with a significant reduction in net debt which is especially welcome in the current high interest rate environment. Group strategy remains intact and in PI that means building the embedded value of future cash flows in NAL while flexing enquiry placements to maximise cash generati